Singapore markets closed
Straits Times Index
3,272.72 +47.55 (+1.47%) S&P 500
5,010.60 +43.37 (+0.87%) Dow
38,239.98 +253.58 (+0.67%) Nasdaq
15,451.31 +169.30 (+1.11%) Bitcoin USD
66,214.05 +272.73 (+0.41%) CMC Crypto 200
1,424.33 +9.58 (+0.68%)
Roche Holding AG (ROG.SW)
Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
As of 01:00PM CEST. Market open.
| Previous close | 225.80 |
| Open | 225.60 |
| Bid | 229.40 x 0 |
| Ask | 229.50 x 0 |
| Day's range | 225.60 - 230.50 |
| 52-week range | 217.00 - 293.55 |
| Volume | |
| Avg. volume | 1,436,599 |
| Market cap | 184.882B |
| Beta (5Y monthly) | 0.15 |
| PE ratio (TTM) | 16.02 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 9.60 (4.25%) |
| Ex-dividend date | 14 Mar 2024 |
| 1y target est | N/A |
- Zacks
Roche (RHHBY) Alecensa Wins FDA Nod for Label Expansion
Roche (RHHBY) has won FDA approval for Alecensa as an adjuvant treatment, following tumor resection for patients with ALK-positive non-small cell lung cancer.
- Zacks
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
J&J (JNJ) posts mixed first-quarter 2024 results. Lilly's (LLY) tirzepatide meets key goals in late-stage studies for obstructive sleep apnea.
- Zacks
Adaptimmune (ADAP) Down on End of Collaboration With Roche
Adaptimmune's (ADAP) shares plummet as the company;s collaboration to develop and commercialize allogeneic cell therapies with Roche gets terminated.
© 2024 Yahoo. All rights reserved.